Relative Bioavailability of MN-166 (Ibudilast) in Extended Release Tablet vs. Intermediate-release Capsule in Healthy Volunteers

Author(s):  
2012 ◽  
Vol 13 (4) ◽  
pp. S77 ◽  
Author(s):  
M. Darwish ◽  
M. Bond ◽  
C. Shu ◽  
P. Robertson ◽  
W. Tracewell

2015 ◽  
Vol 35 (5) ◽  
pp. 291-297 ◽  
Author(s):  
Mona Darwish ◽  
Ronghua Yang ◽  
William Tracewell ◽  
Philmore Robertson ◽  
Mary Bond

Pain Medicine ◽  
2017 ◽  
Vol 19 (8) ◽  
pp. 1597-1612
Author(s):  
Mary Bond ◽  
Kerri A Schoedel ◽  
Laura Rabinovich-Guilatt ◽  
Maciej Gasior ◽  
William Tracewell ◽  
...  

2017 ◽  
Vol 34 (6) ◽  
pp. 1187-1192 ◽  
Author(s):  
Rajendar K. Mittapalli ◽  
Silpa Nuthalapati ◽  
Alyssa E. Delke DeBord ◽  
Hao Xiong

RSC Advances ◽  
2016 ◽  
Vol 6 (41) ◽  
pp. 34110-34119 ◽  
Author(s):  
Srinivasulu Aitipamula ◽  
Annie B. H. Wong ◽  
Pui Shan Chow ◽  
Reginald B. H. Tan

Novel solid forms of an anti-inflammatory drug, oxaprozin, were identified. A drug–drug salt of oxaprozin with salbutamol was proved promising for development of extended release tablet formulations of salbutamol.


Sign in / Sign up

Export Citation Format

Share Document